Connect Biopharma Holdings Limited Ordinary Shares (CNTB) is a publicly traded Healthcare sector company. As of July 14, 2026, CNTB trades at $2.26 with a market cap of $158.04M and a P/E ratio of -1.95. CNTB moved -10.16% today. Year to date, CNTB is -16.30%; over the trailing twelve months it is +48.68%. Its 52-week range spans $0.51 to $3.82. Analyst consensus is strong buy with an average price target of $7.07. Rallies surfaces CNTB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for CNTB, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $2.26 |
| Market Cap | $158.04M |
| P/E Ratio | -1.95 |
| EPS | $-1.15 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.82 |
| 52-Week Low | $0.51 |
| Volume | 477.83K |
| Avg Volume | 0 |
| Revenue (TTM) | $233.00K |
| Net Income | $-64.61M |
| Gross Margin | 0.00% |
7 analysts cover CNTB: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.07.